Mutation analysis of circulating plasma DNA to determine response to EGFR tyrosine kinase inhibitor therapy of lung adenocarcinoma patients

Mutation analysis of circulating plasma DNA to determine response to EGFR tyrosine kinase inhibitor therapy of lung adenocarcinoma patients

Saved in:
Bibliographic Details
Main Authors: Riediger, Anja Lisa (Author) , Dietz, Steffen (Author) , Schirmer, Uwe (Author) , Meister, Michael (Author) , Heinzmann-Groth, Ingrid (Author) , Schneider, Marc (Author) , Muley, Thomas (Author) , Thomas, Michael (Author) , Sültmann, Holger (Author)
Format: Article (Journal)
Language:English
Published: 19 September 2016
In: Scientific reports
Year: 2016, Volume: 6
ISSN:2045-2322
DOI:10.1038/srep33505
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1038/srep33505
Verlag, kostenfrei, Volltext: https://www.nature.com/articles/srep33505
Get full text
Author Notes:Anja Lisa Riediger, Steffen Dietz, Uwe Schirmer, Michael Meister, Ingrid Heinzmann-Groth, Marc Schneider, Thomas Muley, Michael Thomas, Holger Sültmann
Description
Summary:Mutation analysis of circulating plasma DNA to determine response to EGFR tyrosine kinase inhibitor therapy of lung adenocarcinoma patients
Item Description:Gesehen am 18.12.2017
Physical Description:Online Resource
ISSN:2045-2322
DOI:10.1038/srep33505